JAK2V617F-positive polycythemia vera and Philadelphia chromosome-positive chronic myeloid leukemia: one patient with two distinct myeloproliferative disorders

被引：0

作者：

N Cambier

A Renneville

T Cazaentre

V Soenen

C Cossement

S Giraudier

N Grardel

J-L Laï

C Rose

C Preudhomme

机构：

[1] Service d'Hématologie Clinique,

[2] Groupe Hospitalier de l'Institut Catholique Lillois (GHICL),undefined

[3] Hôpital Saint-Vincent,undefined

[4] Unité 837,undefined

[5] INSERM,undefined

[6] Institut de Recherche sur le Cancer de Lille,undefined

[7] and North West Cancéropole,undefined

[8] Laboratoire d'Hématologie,undefined

[9] Centre de Biologie-Pathologie,undefined

[10] CHRU de Lille,undefined

[11] Laboratoire d'Hématologie,undefined

[12] Assistance Publique-Hôpitaux Paris (AP-HP),undefined

[13] Hôpital Henri Mondor and Université Paris XII,undefined

[14] Laboratoire de Cytogénétique,undefined

[15] Hôpital Jeanne de Flandres,undefined

[16] CHRU de Lille,undefined

来源：

Leukemia | 2008年 / 22卷

关键词：

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1454 / 1455

页数：1

共 50 条

[31] Evaluation of V617F mutation of JAK2 in negative chromosome Philadelphia chronic myeloproliferative disorders
Remacha, Angel F.
Puget, Guiomar
Nomdedeu, Josep F.
Estivill, Camino
Pilar Sarda, M.
Canals, Carme
MEDICINA CLINICA, 2006, 127 (16): : 601 - 604
[32] Dasatinib - In chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia
Keam, Susan J.
BIODRUGS, 2008, 22 (01) : 59 - 69
[33] DasatinibIn Chronic Myeloid Leukemia and Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia
Susan J. Keam
BioDrugs, 2008, 22 : 59 - 69
[34] MOLECULAR DIAGNOSIS OF PHILADELPHIA CHROMOSOME-POSITIVE CHRONIC MYELOID-LEUKEMIA
ZACCARIA, A
TASSINARI, A
GUERRASIO, A
ROSSO, C
LOCOCO, F
DIVERIO, D
TESTONI, N
CELSO, B
BUZZI, M
TURA, S
SAGLIO, G
HAEMATOLOGICA, 1991, 76 (03) : 183 - 187
[35] Myeloid blasts in transformed JAK2-V617F positive myeloproliferative disorders are frequently negative for the JAK2-V617F mutation.
Theocharides, Alexandre
Boissinot, Marjorie
Garand, Richard
Girodon, Francois
Teo, Soon-Siong
Lippert, Eric
Tichelli, Andre
Hermouet, Sylvie
Skoda, Radek C.
BLOOD, 2006, 108 (11) : 115A - 115A
[36] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Outi Kilpivaara
Semanti Mukherjee
Alison M Schram
Martha Wadleigh
Ann Mullally
Benjamin L Ebert
Adam Bass
Sachie Marubayashi
Adriana Heguy
Guillermo Garcia-Manero
Hagop Kantarjian
Kenneth Offit
Richard M Stone
D Gary Gilliland
Robert J Klein
Ross L Levine
Nature Genetics, 2009, 41 : 455 - 459
[37] A germline JAK2 SNP is associated with predisposition to the development of JAK2V617F-positive myeloproliferative neoplasms
Kilpivaara, Outi
Mukherjee, Semanti
Schram, Alison M.
Wadleigh, Martha
Mullally, Ann
Ebert, Benjamin L.
Bass, Adam
Marubayashi, Sachie
Heguy, Adriana
Garcia-Manero, Guillermo
Kantarjian, Hagop
Offit, Kenneth
Stone, Richard M.
Gilliland, D. Gary
Klein, Robert J.
Levine, Ross L.
NATURE GENETICS, 2009, 41 (04) : 455 - 459
[38] Concomitant JAK2 V617F-Positive Polycythemia Vera and BCR-ABL-Positive Chronic Myelogenous Leukemia Treated with Ruxolitinib and Dasatinib
Knoche, Eric M.
Fisher, Daniel A. C.
Rippberger, Gregory
He, Li
Moore, Deborah M.
Klein, Jonathan L.
Oh, Stephen T.
BLOOD, 2012, 120 (21)
[39] Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib
A Zhou
E M Knoche
E K Engle
D A C Fisher
S T Oh
Blood Cancer Journal, 2015, 5 : e351 - e351
[40] Concomitant JAK2 V617F-positive polycythemia vera and BCR-ABL-positive chronic myelogenous leukemia treated with ruxolitinib and dasatinib
Zhou, A.
Knoche, E. M.
Engle, E. K.
Fisher, D. A. C.
Oh, S. T.
BLOOD CANCER JOURNAL, 2015, 5 : e351 - e351

← 1 2 3 4 5 →